14 results
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
Insulin Analogs ... , Duration #Diabetes ... #Insulin #Analogs ... #Pharmacology # ... Endocrinology #Timing
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Ketoacidosis (DKA ... deficit: - Type I DM ... - Type II DM ... pathophysiology #comparison ... #endocrinology
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
and Duration #Diabetes ... #Insulin #Analogs ... Duration #Peaks #Comparison ... #Pharmacology # ... Endocrinology #Timing
The graph illustrates the differences in the onset and duration of action for various types of
Detemir, Glargine #Diabetes ... #Insulin #Analogs ... Timeline #Graph #Comparison ... #Pharmacology # ... Endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... medications #table #comparison ... #management #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table ... #endocrinology
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... cells, triggering insulin ... Sulfonylureas #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
including most type 1 diabetics ... including most 2 diabetics ... Weight #Based #pharmacology ... #endocrinology ... #diabetes #DM2
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... • Increases insulin-mediated ... #Metformin #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... • Euglycemic diabetic ... ketoacidosis (DKA ... #Summary #DM2 # ... diabetes #endocrinology